Realveolarization with inhalable mucus-penetrating lipid nanoparticles for the treatment of pulmonary fibrosis in mice
Science Advances · 14.06.2024 · 10 (24)
DOI: 10.1126/sciadv.ado4791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 14.06.2024. Verfasst von Yan Wang und 20 weiteren Autor:innen. Beteiligte Einrichtung: NMPA Key Laboratory for Technology Research and Evaluation of Drug Products and Key Laboratory of Chemical Biology (Ministry of Education), Departmen…. Hauptthemen laut MEDLINE: Nanoparticles, Mucus, Bleomycin. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The stemness loss–associated dysregeneration of impaired alveolar type 2 epithelial (AT2) cells abolishes the reversible therapy of idiopathic pulmonary fibrosis (IPF). We here report an inhalable mucus-penetrating lipid nanoparticle (LNP) for codelivering dual mRNAs, promoting realveolarization via restoring AT2 stemness for IPF treatment. Inhalable LNPs were first formulated with dipalmitoylphosphatidylcholine and our in-house–made ionizable lipids for high-efficiency pulmonary mucus penetration and codelivery of dual messenger RNAs (mRNAs), encoding cytochrome b5 reductase 3 and bone morphogenetic protein 4, respectively. After being inhaled in a bleomycin model, LNPs reverses the mitochondrial dysfunction through ameliorating nicotinamide adenine dinucleotide biosynthesis, which inhibits the accelerated senescence of AT2 cells. Concurrently, pathological epithelial remodeling and fibroblast activation induced by impaired AT2 cells are terminated, ultimately prompting alveolar regeneration. Our data demonstrated that the mRNA-LNP system exhibited high protein expression in lung epithelial cells, which markedly extricated the alveolar collapse and prolonged the survival of fibrosis mice, providing a clinically viable strategy against IPF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- NMPA Key Laboratory for Technology Research and Evaluation of Drug Products and Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College…
- Department of Emergency, Qilu Hospital of Shandong University, 107 Wenhua Xi Road, Jinan, Shandong Province 250012, China.
- Lingyi iTECH Manufacturing Co. Ltd., No. 2988, Taidong Road, Xiangcheng District, Suzhou, Jiangsu Province 215000, China.
- Key Laboratory for Experimental Teratology of Ministry of Education, Key Laboratory of Infection and Immunity of Shandong Province and Department of Immunology, School of Basic Medical Sciences, Cheeloo Medical College…
- Department of Radiology, Qilu Hospital of Shandong University, 107 Wenhua Xi Road, Jinan, Shandong Province 250012, China.
- Shandong University of Traditional Chinese Medicine, Jinan, Shandong Province 250355, China.
ORCID-Profile: Yan Wang, Jing Zhang, Ying Liu, Zhipeng Fu, Chunwei Tang, Chongdeng Shi, Yulin Zhang, Chen Chen, Anning Li, Danqing Zhu, Kun Zhao, Xinyi Jiang
Zitieren
APA
Wang, Y., Zhang, J., Liu, Y., Yue, X., Han, K., Kong, Z., Dong, Y., Yang, Z., Fu, Z., Tang, C., Shi, C., Zhao, X., Han, M., Wang, Z., Zhang, Y., Chen, C., Li, A., Sun, P., Zhu, D., …, & Jiang, X. (2024). Realveolarization with inhalable mucus-penetrating lipid nanoparticles for the treatment of pulmonary fibrosis in mice. Science Advances, 10(24). https://doi.org/10.1126/sciadv.ado4791
Vancouver
Wang Y, Zhang J, Liu Y, Yue X, Han K, Kong Z, et al. Realveolarization with inhalable mucus-penetrating lipid nanoparticles for the treatment of pulmonary fibrosis in mice. Science Advances. 2024;10(24). doi:10.1126/sciadv.ado4791
BibTeX
@article{Wang2024,
author = {Wang, Yan and Zhang, Jing and Liu, Ying and Yue, Xiao and Han, Kun and Kong, Zhichao and Dong, Yuanmin and Yang, Zhenmei and Fu, Zhipeng and Tang, Chunwei and Shi, Chongdeng and Zhao, Xiaotian and Han, Maosen and Wang, Zhibin and Zhang, Yulin and Chen, Chen and Li, Anning and Sun, Peng and Zhu, Danqing and Zhao, Kun and Jiang, Xinyi},
title = {Realveolarization with inhalable mucus-penetrating lipid nanoparticles for the treatment of pulmonary fibrosis in mice},
journal = {Science Advances},
year = {2024},
volume = {10},
number = {24},
doi = {10.1126/sciadv.ado4791}
}
EUVIMED